These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 3768072)

  • 1. Cardiovascular profiles of the calcium antagonists nisoldipine and nifedipine in the blood-perfused dog heart.
    Takahashi K; Taira N
    Arzneimittelforschung; 1986 Jul; 36(7):1054-9. PubMed ID: 3768072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of coronary vasodilator and cardiac effects of nitrendipine by use of isolated, blood-perfused dog heart preparations.
    Satoh K; Wada Y; Taira N
    Arzneimittelforschung; 1986; 36(1):35-9. PubMed ID: 2937413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular actions of the dihydropyridine calcium antagonist nimodipine in the dog.
    Satoh K; Kawada M; Wada Y; Taira N
    Arzneimittelforschung; 1984; 34(5):563-8. PubMed ID: 6540573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selectivity of alinidine, a bradycardic agent, for SA nodal automaticity versus other cardiac activities in isolated, blood-perfused dog-heart preparations.
    Kawada M; Satoh K; Taira N
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):88-102. PubMed ID: 6517649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analyses of the cardiac action of the bradycardic agent, AQ-A 39, by use of isolated, blood-perfused dog-heart preparations.
    Kawada M; Satoh K; Taira N
    J Pharmacol Exp Ther; 1984 Feb; 228(2):484-90. PubMed ID: 6694121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioselective effects of gallopamil compared with verapamil in the dog heart.
    Takahashi K; Tsuchida K; Aihara H
    Arch Int Pharmacodyn Ther; 1988; 295():157-73. PubMed ID: 3245731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separation of the coronary vasodilator from the cardiac effects of PN 200-110, a new dihydropyridine calcium antagonist, in the dog heart.
    Wada Y; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1985; 7(1):190-6. PubMed ID: 2580142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary vasodilator compared to cardiac effects of PY 108-068, a new dihydropyridine vasodilator, on isolated, blood-perfused dog-heart preparations.
    Wada Y; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1984; 6(5):881-7. PubMed ID: 6209495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular profile of Ro 40-5967, a new nondihydropyridine calcium antagonist, delineated in isolated, blood-perfused dog hearts.
    Orito K; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):293-9. PubMed ID: 7692172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary vasodilator and cardiac effects of NKY-722, a novel hydrophilic 1,4-dihydropyridine derivative, in the blood-perfused dog heart.
    Imagawa J; Satoh K; Taira N
    Cardiovasc Drugs Ther; 1989 Mar; 3(1):81-90. PubMed ID: 2487526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are the cardiovascular effects of gentamicin similar to those of calcium antagonists?
    Gotanda K; Yanagisawa T; Satoh K; Taira N
    Jpn J Pharmacol; 1988 Jul; 47(3):217-27. PubMed ID: 3221528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac versus coronary dilator effects of SD-3211, a new nondihydropyridine calcium antagonist, in isolated, blood-perfused dog hearts.
    Yoneyama F; Yamada H; Satoh K; Taira N
    Cardiovasc Drugs Ther; 1990 Dec; 4(6):1469-76. PubMed ID: 2081139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile of coronary vasodilator and cardiac actions of bepridil revealed by use of isolated, blood-perfused heart preparations of the dog.
    Kawada M; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1983; 5(4):604-12. PubMed ID: 6193358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular profile of Bay K 8644, a presumed calcium channel activator, in the dog.
    Wada Y; Satoh K; Taira N
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):382-7. PubMed ID: 2581147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of vasodilating effects of nisoldipine and nifedipine in anesthetized open-chest dogs.
    Sakanashi M; Noguchi K; Kato T; Sunagawa R; Nagamine F; Nakasone J
    Arzneimittelforschung; 1986 Dec; 36(12):1736-9. PubMed ID: 3566835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms underlying the cardiovascular action of a new dihydropyridine vasodilator YC-93.
    Satoh K; Yanagisawa T; Taira N
    Clin Exp Pharmacol Physiol; 1980; 7(3):249-62. PubMed ID: 7406961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is antagonism by Bay k 8644 of the negative dromotropic effect of nifedipine pharmacological?
    Taira N; Wada Y; Satoh K
    J Pharmacol Exp Ther; 1985 Jan; 232(1):244-50. PubMed ID: 2578189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac versus coronary vasodilator actions of KB-944, a new calcium antagonist, assessed in isolated, blood-perfused heart preparations of dogs.
    Taira N; Kawada M; Satoh K
    J Cardiovasc Pharmacol; 1983; 5(3):349-56. PubMed ID: 6191131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.